drugset

drugset / Trial / NCT01519687

Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout

NCT01519687 ↗

Phase 2 Unknown 20 enrolled Pharmos

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether levotofisopam is safe and effective in the treatment of hyperuricemia and gout.

Timeline

Start: 2012-01
Primary completion: 2012-06
Completion: 2012-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	levotofisopam	Small molecule	50 mg	—

Indications